
IPM Receives License from Janssen to Develop FDA-Approved HIV-1 Drug as Microbicide for HIV Prevention
December 2015
Click for full info +IPM Receives License from Janssen to Develop FDA-Approved HIV-1 Drug as Microbicide for HIV Prevention
![]() | 01 December 2015 |
In this Press Release:
Health Risk(s):HIV
Product Type(s):Microbicides
Topic(s):Product Development
Full Info:
Resource Type:
Citation:
(2015, December 1). International Partnership for Microbicides.
Authors:
[No authors listed]
Health Risks(s):
- HIV
Product type(s):
- Microbicide
Topic(s):
- Development
URL of resource: